Tourniquet Exposure and Risk of Chronic Pain After Severe Limb Trauma
TOURNI-PAIN
2 other identifiers
observational
150
1 country
1
Brief Summary
Severe limb trauma often requires the use of a tourniquet to stop life-threatening bleeding. While tourniquets are essential for saving lives, prolonged interruption of blood flow may lead to tissue ischemia, nerve injury, and inflammatory responses that could contribute to the development of chronic pain. The TOURNI-PAIN Study is a prospective observational study designed to investigate whether the duration of tourniquet use during the treatment of severe limb injuries is associated with an increased risk of persistent pain after recovery. The study will enroll adult patients with major upper or lower limb trauma who required tourniquet application in the prehospital or hospital setting. Researchers will collect information about the duration and characteristics of tourniquet use, details of the injury, surgical treatment, and recovery. Participants will be followed for up to 6 months after injury to assess pain levels, possible neuropathic pain, functional recovery, and quality of life. The goal of this research is to better understand whether longer tourniquet exposure increases the risk of long-term pain. The findings may help improve trauma care practices by balancing the life-saving benefits of hemorrhage control with strategies that minimize long-term complications and improve recovery for patients with severe limb injuries.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 13, 2026
CompletedStudy Start
First participant enrolled
March 15, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 15, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 15, 2026
CompletedFirst Posted
Study publicly available on registry
March 17, 2026
CompletedMarch 18, 2026
March 1, 2026
Same day
March 13, 2026
March 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Persistent Clinically Significant Pain After Limb Trauma
Persistent pain defined as Numeric Rating Scale (NRS) ≥4 during movement or functional activity at 3 or 6 months after injury. Pain intensity will be assessed using the standardized 0-10 Numeric Rating Scale during follow-up evaluations.
3 and 6 months after injury
Secondary Outcomes (1)
Neuropathic Pain
3 and 6 months after injury
Study Arms (1)
Severe Limb Trauma With Tourniquet Exposure
This cohort includes adult patients with severe upper or lower limb trauma who required tourniquet application for hemorrhage control in the prehospital or hospital setting. The study is observational and does not involve any study-mandated intervention. Clinical care will follow institutional trauma protocols. The primary exposure of interest is cumulative tourniquet duration (minutes). Participants will be followed prospectively to evaluate the association between tourniquet exposure and the development of persistent pain, neuropathic pain, functional outcomes, and quality of life up to 6 months after injury.
Eligibility Criteria
The study population will include adult patients (≥18 years) with severe upper or lower limb trauma who required tourniquet application for hemorrhage control in the prehospital or hospital setting. Participants will be recruited from trauma centers treating combat-related and civilian traumatic injuries. Eligible patients must have documented tourniquet use and available information on tourniquet duration. The cohort will include patients undergoing limb salvage as well as those requiring primary or secondary amputation. Participants will be followed prospectively to assess the relationship between tourniquet exposure and the development of persistent pain and functional outcomes.
You may qualify if:
- Age ≥18 years
- Severe upper or lower limb trauma
- Documented tourniquet use (prehospital or in-hospital)
- Available documentation of tourniquet duration
- Informed consent
You may not qualify if:
- Pre-existing chronic limb pain
- Known severe peripheral neuropathy
- Cognitive inability to complete follow-up
- Expected survival \<48 hours
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Superhumans War Trauma Center
Lviv, Ukraine
Related Publications (1)
Kragh JF Jr, Walters TJ, Baer DG, Fox CJ, Wade CE, Salinas J, Holcomb JB. Practical use of emergency tourniquets to stop bleeding in major limb trauma. J Trauma. 2008 Feb;64(2 Suppl):S38-49; discussion S49-50. doi: 10.1097/TA.0b013e31816086b1.
PMID: 18376170RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chief of science department, PhD, Professor
Study Record Dates
First Submitted
March 13, 2026
First Posted
March 17, 2026
Study Start
March 15, 2026
Primary Completion
March 15, 2026
Study Completion
March 15, 2026
Last Updated
March 18, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be publicly shared due to ethical, legal, and security considerations related to sensitive clinical data from trauma patients, including those with combat-related injuries. Data may contain potentially identifiable health information and details associated with military trauma. De-identified aggregated data may be shared upon reasonable request and subject to approval by the study investigators and institutional ethics committees, in accordance with institutional policies and applicable data protection regulations.